Nonalcoholic Steatohepatitis Therapeutics Market1
number of obese adults and children in the U.S. have doubled and tripled, respectively. This is a major issue, as obese patients who suffer from NFALD or NASH are also likely to suffer from high blood cholesterol and diabetes. Apart from obesity, patients of glucose intolerance and dyslipidemia are also prone to suffer from NFALD and NASH. There is no clear link that points to the reason NFALD occurs, but it is currently suggested that insulin resistance has a major role to play in it. In spite of the severity of the disease, patients are largely asymptomatic until complications arise. Therefore, the best preventive measure against NFALD and NASH is to lead a healthy life and moderate alcohol consumption. Browse Full Press Release on Nonalcoholic Steatohepatitis Therapeutics Market: Press Release About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information. TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com
- Page 1 and 2: Nonalcoholic Steatohepatitis Therap
- Page 3: therapeutics market. Elafibranor is
number of obese adults and children in the U.S. have doubled<br />
and tripled, respectively. This is a major issue, as obese patients<br />
who suffer from NFALD or NASH are also likely to suffer from<br />
high blood cholesterol and diabetes.<br />
Apart from obesity, patients of glucose intolerance and<br />
dyslipidemia are also prone to suffer from NFALD and NASH.<br />
There is no clear link that points to the reason NFALD occurs,<br />
but it is currently suggested that insulin resistance has a major<br />
role to play in it. In spite of the severity of the disease, patients<br />
are largely asymptomatic until complications arise. Therefore,<br />
the best preventive measure against NFALD and NASH is to<br />
lead a healthy life and moderate alcohol consumption.<br />
Browse Full Press Release on <strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong><br />
<strong>Therapeutics</strong> Market:<br />
Press Release<br />
About Us<br />
Transparency Market Research (TMR) is a global market<br />
intelligence company providing business information reports<br />
and services. The company’s exclusive blend of quantitative<br />
forecasting and trend analysis provides forward-looking insight<br />
for thousands of decision makers. TMR’s experienced team of<br />
analysts, researchers, and consultants use proprietary data
Change language